Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer

NCT00094081 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00094081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00094081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2002
Completion date
September 30, 2006
Enrollment
861 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck neoplasms